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Abstract
Recent reports indicate that Smad7 promotes skeletal muscle differentiation and growth. We previously documented
a non-canonical role of nuclear Smad7 during myogenesis, independent of its role in TGF-β signaling. Here further
characterization of the myogenic function of Smad7 revealed β-catenin as a Smad7 interacting protein. Biochemical
analysis identiﬁed a Smad7 interaction domain (SID) between aa575 and aa683 of β-catenin. Reporter gene analysis
and chromatin immunoprecipitation demonstrated that Smad7 and β-catenin are cooperatively recruited to the
extensively characterized ckm promoter proximal region to facilitate its muscle restricted transcriptional activation in
myogenic cells. Depletion of endogenous Smad7 and β-catenin in muscle cells reduced ckm promoter activity
indicating their role during myogenesis. Deletion of the β-catenin SID substantially reduced the effect of Smad7 on
the ckm promoter and exogenous expression of SID abolished β-catenin function, indicating that SID functions as a
trans dominant-negative regulator of β-catenin activity. β-catenin interaction with the Mediator kinase complex
through its Med12 subunit led us to identify MED13 as an additional Smad7-binding partner. Collectively, these studies
document a novel function of a Smad7-MED12/13-β-catenin complex at the ckm locus, indicating a key role of this
complex in the program of myogenic gene expression underlying skeletal muscle development and regeneration.
Introduction
Developmental myogenesis, the process of terminal
differentiation of skeletal muscle progenitor cells, consists
of a series of well-characterized highly regulated steps that
has become a paradigm for lineage acquisition and cel-
lular differentiation1–5. During embryogenesis, plur-
ipotent mesodermal stem cells commit to become
myogenic progenitor cells6. Commitment to the myogenic
lineage results in a binary state of either maintenance of
proliferative potential and multipotency or, on appro-
priate cues, withdrawal from the cell cycle, activation of a
battery of structural, contractile, and metabolic genes and
ultimately formation of multi-nucleated, electrically
excitable myoﬁbers1,7,8. Also, in adult skeletal muscle,
resident stem cells (satellite cells) located between the
basal lamina and the plasma membrane of mature muscle
ﬁbers9 recapitulate this “myogenic program” of differ-
entiation in response to injury or for routine maintenance
of the muscle tissue10.
How networks of transcriptional regulators exert
molecular control over developmental and adult myo-
genesis has been a prevalent theme in understanding the
molecular control of ontogeny, physiology, and pathology
of the striated muscle10–12. Extensive biochemical and
genetic evidence has implicated a family of DNA-binding
transcriptional regulatory proteins encoded by the myo-
genic regulatory factor (MRF) genes, myf5, myod1, myo-
genin (myog), and mrf4, in myogenesis10,13. In conjunction
with the proteins encoded by the myocyte enhancer factor
2 (mef2a-d) gene family, the MRF’s activate an evolutio-
narily conserved program of gene expression, which leads
to the generation of terminally differentiated skeletal
muscle cells14–16. Understanding the trans-acting factors
contributing to this process has been aided in tandem by
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extensive analysis of the cis-regulatory elements of mus-
cle-restricted, differentiation-induced genes such as the
muscle creatine kinase (ckm) gene17–19.
In addition to the central role played by the MRF/MEF2
axis in myogenesis20, other transcription factors have
been implicated in the control of myogenic differentiation
such as Six 1 and 421–23, AP-124,25, β-catenin26–28, and
Smad729–31. Since our initial observations of the pro-
myogenic role of Smad7 in cultured muscle cells29, we
have documented a novel nuclear role for Smad7 in
muscle that is essentially independent of its “canonical”
role as a repressor of transforming growth factor (TGF)-β
signaling31. In addition, other groups have documented an
in vivo role for Smad7 in the skeletal muscle30. Under-
standing the nature of the ancillary role played by Smad7
and other transcriptional regulators at muscle-restricted
genes is therefore of some importance for our overall
understanding of the molecular programming of myo-
genic identity.
In view of the “non-canonical” nuclear role of Smad7
alluded to above, the mechanistic basis by which it con-
tributes to the myogenic differentiation program is so far
incompletely understood. We were intrigued by a report
identifying a protein–protein interaction (PPI) between
Smad7 and β-catenin in human prostate cancer cells32
since both are known, independently, to be key regulators
of muscle gene expression in a variety of contexts. We
therefore assessed this putative PPI in cultured muscle
cells. Our data support a robust interaction between
Smad7 and β-catenin that contributes to the transcrip-
tional control of a key myogenic promoter (ckm). We
further extended these observations in characterizing the
recruitment of Mediator components (Med12/13) by the
β-catenin/Smad7 complex, thus connecting the muscle
transcriptosome assembled on enhancers such as ckm to
the basal transcription machinery. Integration of the
Smad7-β-catenin complex into the network of proteins
regulating the “myogenic program” expands our under-
standing of the unique molecular wiring encoding myo-
genic differentiation, growth and repair.
Materials and methods
Cell culture
C2C12 myoblasts were obtained from the American
Type Culture Collection. Cells were cultured in growth
medium (GM) consisting of high-glucose Dulbecco’s
modiﬁed Eagle’s medium (DMEM, Gibco), 10% fetal
bovine serum (FBS), and L-Glutamine (HyClone) sup-
plemented with 1% penicillin–streptomycin (Invitrogen,
ThermoFisher). Myotube formation was induced by
replacing GM with differentiation medium (DM), con-
sisting of DMEM supplemented with 2% horse serum
(Atlanta Biologicals) and 1% penicillin–streptomycin.
Cells were maintained in an incubator at 95% humidity,
5% CO2, and 37 °C.
Transfections
For ectopic protein expression, cells were transfected
using the calcium phosphate precipitation method for
transcription reporter assays. Cells were re-fed 16 h post-
transfection and harvested. For small interfering RNA
(siRNA) experiments, cells were transfected with Lipo-
fectamine 2000 (Life Technologies) using instructions
provided by the manufacturer and harvested 48 h later,
unless otherwise indicated.
Gene silencing
MISSION siRNA (Sigma-Aldrich) for rat and mouse
ctnnb1 siβ-catenin#1 (SASI_Rn01_00099925), siβ-catenin
#2 (SASI_Rn01_00099923), siβ-catenin#3 (SASI_Rn01_00
099924), siSmad7#1 (SASI_Mm02_00290887), siSmad7#2
(SASI_Mm02_00290886), siSmad7#3 (SASI_Mm02_0029
0885) and universal scrambled siRNA (SIC001) were used
at 75 nM concentrations.
Plasmids
Expression plasmids for Myc-His-tagged full-length
Smad7, β-catenin-myc, transcription reporter assay con-
structs pckm-luc have been described previously29,31,33.
β-catenin mutant expression plasmids were constructed
by the ligation of PCR-ampliﬁed nucleotides corre-
sponding to the indicated amino acid (aa) regions
(aa575–683, aa1–574) at Hind III and Xho I sites of
pcDNA3-EYFP or pcDNA3-3Xﬂag-8XHis, respectively.
Constructs for expression of glutathione-S-transferase
(GST)-fused β-catenin fragments were described
previously34.
Transcription reporter gene assays
Transcriptional reporter assays were performed using
luciferase reporter plasmids along with expression con-
structs (indicated in the ﬁgure legends) and a Renilla
plasmid (pRL-Renilla, Promega) as an internal control.
Cells were washed with 1× phosphate-buffered saline and
harvested in Luciferase Lysis Buffer (20 mM Tris pH 7.4
and 0.1% Triton X-100). Enzymatic activity was measured
in each sample on a luminometer (Lumat LB, Berthold)
using Luciferase assay substrate (E1501; Promega) or
Renilla assay substrate (E2820; Promega). Luciferase
activity values obtained were normalized to Renilla
activity in the same cell extracts and expressed as fold
activation to the control.
Nuclear and cytoplasmic extraction
Nuclear and cytoplasmic extraction was obtained using
the NE-PER Kit (78833; Thermo Scientiﬁc), as per the
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instructions provided by the manufacturer. Immuno-
blotting of extracellular signal-regulated kinase and c-Jun
was used as the positive control for cytoplasmic and
nuclear fractions, respectively.
Western blot analysis
Total cellular protein extracts were prepared in NP-40
lysis buffer (0.5% (vol/vol)), 50 mM Tris-HCl (pH
8),150 mM NaCl, 10 mM sodium pyrophosphate, 1 mM
EDTA (pH 8), and 0.1M NaF supplemented with 1×
protease inhibitor cocktail (P-8340; Sigma) and 0.5 mM
sodium orthovanadate. Protein concentrations were
determined by a standard Bradford assay. Equivalent
amounts of protein were denatured in sodium dodecyl
sulfate (SDS) loading buffer at 100 °C for 5 min and then
run in SDS-polyacrylamide gels, followed by electro-
phoretic transfer to an Immobilon-FL polyvinylidene
diﬂuoride membrane (Millipore) as directed by the
manufacturer. Blots were incubated with blocking buffer
that consisted of 5% milk in Tris-buffered saline (TBS)-T
(10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.1% Tween 20)
prior to the incubation with primary antibody at 4 °C
overnight with gentle agitation. After three washes with
TBS-T, appropriate horseradish peroxidase-conjugated
secondary antibody (BioRad, 1:2000) were added for 2 h at
room temperature. Protein/antibody immune-complexes
were detected with Enhanced Chemiluminescence wes-
tern blotting substrate (Pierce, ThermoFisher).
Antibodies
Rabbit monoclonal for αSmad7 (ab124890) and poly-
clonal for αMED13 (ab76923) and αMED12 (ab70842) were
purchased from Abcam. A rabbit polyclonal antibody was
raised against GST-Smad7 according to the protocol
approved by York University of Animal Care Committee.
This was used for endogenous Smad7 immunoprecipitation
(IP) and detection in cellular and nuclear extract.
αβ-Catenin (pAb9562) and ChIP-grade αFlag antibody
(mAb 14793S) were purchased from Cell signaling.
Monoclonal αFlag antibody (F1804) was from Sigma. αMyc
(9E10), αMyHC (MF20), and αMyogenin (F5D) were pur-
chased from DSHB. αActin (Sc1616), αMyoD (sc304), and
αCKM (sc-69878) were purchased from Santa Cruz.
Co-immunoprecipitation (Co-IP)
For Co-IP, cells were harvested, and proteins were
extracted as described above. IP was performed using an
ImmunoCruz Optima Kit (Santa Cruz Biotechnology)
according to the manufacturer’s instructions. Eluates were
analyzed by western blotting as described above.
Live-cell imaging
C2C12 cells were seeded onto the glass-bottom dishes
(MatTek Corp). The cells were transfected for the
expression of ﬂuorescent-tagged proteins. Before imaging
the cells, the media was replaced for FluoroBrite DMEM
(Thermo Fisher Scientiﬁc) supplemented with 10% FBS.
To mark nuclei, Hoechst 33342 (Sigma-Aldrich) was
added to 2.5 µM into the media. After 30 min, the stained
cells were visualized by a Carl Zeiss Spinning disc system
(Zeiss Observer Z1 with Yokogawa CSU-X1 and Axio-
Cam MRm camera) in the environment chamber (37 °C,
5% CO2). The raw images were processed by ZEN (Carl
Zeiss) to obtain pseudo-colored micrographs.
Chromatin immunoprecipitation (ChIP)
C2C12 myoblasts or Smad7-Flag ectopically expressing
myoblasts were crosslinked with 1% formaldehyde fol-
lowed by sonication to shear DNA strands attached to the
protein. Smad7/β-catenin was immunoprecipitated with
Flag or β-catenin antibody to obtain the protein–DNA
complex. IP with IgG antibody served as controls.
Immunoprecipitated DNA was reverse crosslinked, pur-
iﬁed, and subjected to quantitative PCR (qPCR) using
primers speciﬁc for the ckm promoter. Primers speciﬁc to
gapdh was used as controls for ckm enrichment.
GST pull down assay
For GST pull down assays, GST-Smad7 and 6XHis-
β-catenin fusion proteins were produced in bacteria using
standard protocol. Brieﬂy, GST-Smad7- and 6XHis-
β-catenin-expressing cells were sonicated and the pro-
teins were puriﬁed with glutathione-agarose beads
(Sigma-Aldrich G-4510). Protein concentrations were
estimated by SDS-polyacrylamide gel electrophoresis and
following Coomassie blue staining, using BSA for com-
parative estimation. GST-β-catenin fragments corre-
sponding to aa (full length (FL), 1–100, 120–683,
422–683, 575–696, 575–683, 1–574) were utilized for
mapping study. Five micrograms of GST FL Smad7,
β-catenin (or the molar equivalent of the smaller GST,
GST-β-catenin fragments), and 25 µl glutathione-agarose
beads (50% slurry) were incubated in 600 µl NETN buffer
(100 mM NaCl, 20 mM Tris-HCl (pH 8) 0.5 mM EDTA,
0.5% (vol/vol) NP-40) overnight at 4 °C. In experiments
where GST-β-catenin was used to co-precipitate Smad7,
GST-Smad7 was thrombin (GE Healthcare-27-0846-01)
digested to yield the immune-complex without the GST
tag (10 µl thrombin per mg fusion protein was incubated
at room temperature for 17 h), and eluates were analyzed
by western blotting.
Results
Smad7 and β-catenin are co-expressed and interact in
myogenic cells
A time course analysis of β-catenin and myogenic
markers during C2C12 differentiation indicated that
β-catenin expression is enhanced along with myosin
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heavy chain (MyHC), muscle creatine kinase (CKM), and
myogenin levels during differentiation (Fig. 1a). Endo-
genous Smad7 protein levels increased during differ-
entiation as compared to myoblasts in growth conditions
(Fig. 1b). Immunoﬂuorescence analysis of Smad7- and
β-catenin-expressing C2C12 cells indicates that both
Smad7 and β-catenin are localized in the nucleus; inter-
estingly, two different patterns of localization were
observed. β-Catenin exhibited a diffuse pattern of locali-
zation within the nucleus in some cells while in others a
very deﬁned co-localization occurred in nuclear puncta
(Fig. 1c). A cytoplasmic and nuclear fractionation
demonstrated that Smad7 and β-catenin are abundant in
both fractions (Fig. 1d). Based on a previous report indi-
cating a PPI between β-catenin and Smad7 in human
prostate cancer cells (PC-3U)32, we assessed whether
Smad7 and β-catenin form a complex under these cellular
conditions in cultured muscle cells and muscle tissue
(mouse tibialis anterior (TA)). Total protein lysates from
mouse TA and C2C12 muscle cells were subjected to Co-
IP with β-catenin and Smad7 antibodies. Interestingly,
Smad7 and β-catenin were precipitated together in
muscle tissue (TA) and in muscle cells (Fig. 1e). The
interaction was further conﬁrmed by ectopically expres-
sing Smad7-Flag followed by detection of β-catenin in the
Co-IP (Fig. 1f).
Smad7 physically interacts with β-catenin
As the Co-IP analysis indicated Smad7 and β-catenin
were in the same complex, we next clariﬁed whether this
was a direct interaction by utilizing GST pull down assays
with bacterially expressed puriﬁed proteins. GST-Smad7
and 6xHistidine (6xHis)-β-catenin fusion protein were
produced to conduct the assay. A Coomassie stained blot
conﬁrmed the puriﬁcation of the fusion proteins (Fig. 2a).
β-catenin immunoprecipitated with GST-Smad7 but not
with GST-conjugated beads indicated that this interaction
was direct (Fig. 2b). Next, we determined the Smad7
interaction domain (SID) on β-catenin. The 781 aa
sequence of β-catenin gives rise to a structure consisting
of several characteristic repeats, termed armadillo repeats,
each approximately 40 aa’s long. N-terminal (NTD) and
C-terminal (CTD) domains ﬂank either end of the
armadillo repeats. Helix-C indicates a conserved helix
Fig. 1 Smad7 and β-catenin interaction and expression during myogenic differentiation. a C2C12 myoblasts were cultured in growth media
(GM) for 24 h, followed by differentiation media (DM) for designated times. Lysates were collected and assessed for the expression of muscle markers
by western blot analysis. b Lysates were combined from several plates for immunoblotting detection of Smad7. Actin was used as loading control. c
Co-localization of Smad7 and β-catenin was analyzed by immunoﬂuorescence in ectopically expressing EYFP-Smad7-NLS and mcherry- β-catenin
C2C12 cells. d Cytoplasmic and nuclear extraction was done to determine the endogenous localization of Smad7 and β-catenin in C2C12 cells.
Extracellular signal-regulated kinase was utilized as cytoplasmic control and c-Jun as nuclear control. e Co-immunoprecipitation (Co-IP) assays were
performed using Smad7 antibody to detect an interaction between endogenous β-catenin and Smad7 in extracts from mouse tibialis anterior (TA)
muscle and C2C12 myoblasts. f Alternatively, in another separate experiment, C2C12 myoblasts were transiently transfected with Smad7-Flag. Smad7-
Flag lysates were utilized for Co-IP with β-catenin or Flag antibody to detect interaction with β-catenin. IP with IgG served as controls
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located adjacent to the last ARM repeat proximal to the
CTD35 (Fig 2c). GST-β-catenin protein fragments corre-
sponding to aa’s 1–106, 120–683, 422–683, 575–696, and
the FL were utilized for determining the interacting
region with Smad7. Smad7 interacted with FL β-catenin
(as we previously identiﬁed) and β-catenin aas 120–683,
422–683 and 575–696. Smad7 did not interact with
β-catenin aa1–106 therefore indicating that the region
between aa575 and aa683 (Fig. 2d) is required for this
interaction. To further reﬁne this, we used additional
GST-β-catenin fragments, GST-β-catenin aa575–683 and
GST-β-catenin aa1–574 and conducted the interaction
assay. In agreement with the above results, we observed
that Smad7 interacted with β-catenin aa575–683 and not
with aa1–574 leading us to conclude that the SID on
β-catenin lies between aa575 and aa683 (Fig. 2e). This
region spans the 10th armadillo repeat of β-catenin and a
partial region extending into the CTD. Previously, this
CTD domain has been associated with β-catenin trans-
activation properties and has been shown to interact with
MED12, TBP (TATA-binding protein), CBP (CREB-
binding protein/p300), and proteins associated with
chromatin regulation35.
Smad7 and β-catenin are enriched on the muscle-speciﬁc
ckm promoter proximal region
The regulatory region of the ckm gene (ckm) has been
extensively characterized and has served as a paradigm for
tissue-restricted transcriptional control during myogen-
esis17,36. Our laboratory previously documented that
Smad7 associates with the promoter proximal elements of
ckm29. We therefore used this as a test promoter to assess
the function of the β-catenin:Smad7 interaction and to
interrogate the role of this complex during myogenic
differentiation. First, ChIP coupled with qPCR for ckm
and gapdh (control) was utilized to assess whether Smad7
and β-catenin are enriched on the ckm promoter proximal
region. In the absence of a Smad7 antibody efﬁcacious for
ChIP, Smad7 enrichment was conﬁrmed by Flag-Smad7
recruitment to the ckm promoter (Fig. 3a). Additionally,
endogenous β-catenin is enriched at the ckm promoter in
myogenic cells (Fig. 3b). Next, we utilized reporter gene
assays in which Smad7 and β-catenin were exogenously
expressed in C2C12 cells along with a ckm (−1082 to
−1262) promoter fragment driving a ﬁreﬂy luciferase
reporter gene. These data indicate that Smad7 and
β-catenin transactivate this promoter region both alone
Fig. 2 β-catenin C terminal domain (aa575–683) comprises a Smad7 interaction domain (SID). a Coomassie blue staining of the puriﬁed
proteins GST (26 kDa), GST-Smad7 (72 kDa), and β-catenin His tag (98 kDa). b Glutathione-S-transferase (GST) pull down assays were performed with
puriﬁed GST-Smad7 and 6× Histidine (6×His)-β-catenin fusion protein expressed in the bacteria. c The β-catenin protein (781aa) consists of a central
region (aa 141–664) made up of 12 Armadillo repeats that are ﬂanked by distinct N-and C-terminal domains, respectively. A speciﬁc conserved helix
(Helix-C) is located proximally to the C-terminal domain, adjacent to the last ARM repeat. d, e Interaction between Smad7 and β-catenin was assessed
by GST pull down assay. Puriﬁed Smad7 was incubated with GST or GST-β-catenin fusion protein fragments along with glutathione-agarose beads;
detection of Smad7 protein complexed with GST-β-catenin fragments were analyzed by immunoblotting with anti-Smad7 polyclonal antibody
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and in combination (Fig. 3c). Based on the interaction
mapping, a mammalian expression vector for β-catenin
without the SID (deletion of aa575–683) was constructed.
Initially, we performed reporter gene assays of the activity
of these β-catenin constructs using the TOP ﬂash luci-
ferase reporter gene, which acts both as a β-catenin
reporter and a general Wnt signaling pathway reporter as
it contains 7 TCF/LEF consensus sites in which TCF/LEF
proteins bind to but cannot activate the reporter gene
without β-catenin. Our data indicated that the FL
β-catenin activated TOP ﬂash, whereas β-catenin 1–574
and β-catenin ΔSID could minimally activate TOP ﬂash
compared to the FL β-catenin (supplementary Fig. S1).
Further, when β-catenin was ectopically expressed with
Smad7, there was an enhancement in TOP ﬂash promoter
activity, whereas there was no change in TOP ﬂash
activity in conditions where Smad7 was expressed in
combination with β-catenin 1–574 and β-catenin ΔSID.
These data revealed that, while Smad7 was able to
enhance the function of the intact β-catenin, it did not co-
operate with β-catenin 1–574 and β-catenin ΔSID in
reporter gene assays (supplementary Fig. S1). We next
deleted the SID domain to test whether it might prevent
the cooperative transactivation mediated by Smad7 and
β-catenin. To test this idea, Smad7, FL β-catenin
(β-catenin-FL), β-catenin (aa1–574, ΔSID) along with a
ckm luciferase construct were ectopically expressed in
C2C12 cells alone or in combination. These data indicate
that, while Smad7 and the β-catenin-FL enhanced the ckm
promoter, this activity was substantially reduced in cells
Fig. 3 Smad7 and β-catenin enhance ckm proximal promoter activity. a, b For chromatin immunoprecipitation (IP), myoblasts expressing
Smad7-Flag or un-transfected myoblasts were crosslinked with 1% formaldehyde followed by sonication to shear DNA (Smad7 or β-catenin). IP with
anti-Flag or β-catenin antibody was carried out to precipitate protein–DNA complexes. Comparable IP with IgG antibody served as control.
Recovered DNA was reverse crosslinked, puriﬁed, and subjected to quantitative PCR (qPCR) using primers speciﬁc for the ckm promoter to determine
enrichment. Primers speciﬁc to gapdh were used as controls. c Combinations of Smad7-myc and β-catenin-myc were ectopically expressed in C2C12
cells along with a ckm luciferase reporter gene. Renilla luciferase served as transfection control. C2C12 transfected with empty vector (pcDNA) and
reporter genes served as controls for ectopic expression. Cells were harvested for Luciferase determination at 48 h after changing to differentiation
media (DM) post-transfection. Normalized luciferase activity was compared to the control to determine fold changes. d C2C12 cells were transfected
with Smad7-myc, β-catenin-FL(full-length)-myc, β-catenin ΔSID, and β-catenin 1-574 alone or in combination with ckm luciferase reporter construct.
e Three small interfering RNAs (siRNAs) speciﬁc for Smad7 were used to deplete the endogenous Smad7 levels in C2C12. Unprogrammed Scrambled
siRNA was used as controls. f β-Catenin was transfected along with ckm luciferase. Empty vector (pcDNA) was used as a control for ectopic
expression. Renilla was used as a control reporter to monitor transfection efﬁciency. Lysates were collected at 48 h after changing to DM post-
transfection. The ﬁreﬂy luciferase activity under each condition was measured independently and normalized to Renilla luciferase values. Each
condition is compared to the control for the three individually transfected samples to determine fold change. Each dot represents one biological
replicate, which corresponds to the mean of three technical replicates. N= 3 biological replicates per condition. The error bars represent standard
error of the mean (SEM). Dunnett’s multiple comparisons test in one-way analysis of variance using GraphPad Prism 8.0 was utilized to test for
statistical signiﬁcance. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001
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expressing Smad7 in combination with β-catenin aa1–574
or β-catenin ΔSID (Fig. 3d). These data support the
conclusion that the β-catenin SID is crucial for the
cooperative interaction of Smad7 and β-catenin on the
ckm promoter. To address this cooperativity in a different
way, we next investigated the effect of perturbation in
Smad7 expression on the function of β-catenin on the
ckm promoter using siRNA technology. Endogenous
Smad7 levels were depleted using three independent
siRNAs (supplementary Fig. S2) and reporter gene ana-
lysis indicated a pronounced decrease in ckm promoter
activity when compared to the control (Fig. 3e). Ectopic
expression of β-catenin in Smad7-depleted cells exhibited
a reduction in ckm promoter induction consistent with
the interpretation that β-catenin requires Smad7 in order
to affect promoter activation (Fig. 3f). To further test this
idea, we correspondingly depleted β-catenin expression
using three independent siRNAs. Western blot analysis
veriﬁed a considerable reduction in protein levels of
β-catenin using two different siRNAs (si#2 and #3) as
compared to controls. Under conditions in which endo-
genous β-catenin was depleted, we observed that Smad7
mediated ckm promoter activation was markedly reduced
(Fig. 4a). These data indicate that both Smad7 and
β-catenin cooperatively activate the ckm promoter. Pre-
viously, it was shown that MyoD, the archetypal MRF37,
interacts with β-catenin38. To test this hypothesis, endo-
genous β-catenin levels were depleted in C2C12 using two
different siRNAs. MyoD and Smad7-myc either alone or
in combination were then transfected along with the ckm
reporter gene in β-catenin-depleted cells. This analysis
revealed that ckm promoter activity increased by Smad7
or/and MyoD was reduced by depletion of β-catenin (Fig.
4b). These results further support the conclusion that
β-catenin enhances Smad7- and MyoD-driven potentia-
tion of ckm promoter activity. These observations in
combination with previously reported data indicate that
the Smad7:β-catenin interaction may be tethered by
MyoD and is required for full ckm promoter activation.
The minimal SID on β-catenin functions as a transdominant
inhibitor of β-catenin activity
Since our data suggested that the SID is crucial for the
function of Smad7 and β-catenin on the ckm promoter,
we next considered the possibility that this domain of
β-catenin might function as a more general transdomi-
nant repressor (dominant negative) of endogenous
β-catenin activity. To test this idea, we constructed a
mammalian expression plasmid for tagged β-catenin
aa575–683. Smad7 and β-catenin were ectopically
expressed in C2C12 cells along with increasing con-
centrations of either EYFP-β-catenin aa575–683 (EYFP-
SID) or Flag β-catenin aa575–683 (Flag-SID). Reporter
gene analysis revealed that ckm promoter activity was
signiﬁcantly reduced in Smad7- and β-catenin-expressing
cells in the presence of either EYFP-SID or Flag-SID (Fig
5a). These data indicate that the β-catenin SID can
function as a dominant-negative inhibitor of β-catenin
function. A similar analysis using a sprr1a promoter
luciferase reporter gene that is not regulated by MyoD
(data not shown) was unaffected by SID expression, sug-
gesting that the effect of SID on ckm is speciﬁc (supple-
mentary Fig. S3). We subsequently assessed the effect of
the SID domain on myogenesis by analyzing the protein
levels of myogenic markers with and without SID
expression. Immunoblot analysis from ectopically
expressed SID in C2C12 cells exhibited reduced protein
levels of CKM and Myogenin as compared to controls
indicating an overall repression of myogenesis by exo-
genous SID expression (Fig. 5b). Collectively these data
suggested that the β-catenin SID can inhibit the activity of
endogenous β-catenin and the myogenic differentiation
program.
Smad7:β-catenin complex interact with the Mediator
kinase complex subunits (MED13 and 12)
Previous studies39 and our unpublished observations
conﬁrm that β-catenin directly interacts with MED12.
Since it is established that MED12 and MED13 form an
integral part of the mediator kinase module39,40, we
hypothesized that the composite function of the Smad7:
β-catenin interaction might be to recruit the MED kinase
module. This idea is supported by our Co-IP analysis in
which we observed that Smad7 and MED13 are in the
same precipitated protein complex (Fig. 6a). Furthermore,
we also validated the previously reported MED12:
β-catenin interaction (Fig. 6b). Finally, we observed that
the Smad7:MED13 interaction was disrupted when
endogenous β-catenin was depleted (Fig. 6c, d). The
Smad7:MED13 interaction thus constitutes a novel
observation in characterizing Smad7 as a component of
the transcriptional machinery-linking promoter activity to
the Mediator kinase complex.
Discussion
Smad7:β-catenin as an essential component of muscle
enhanceosomes
Despite a considerable body of literature implicating
Wnt-β-catenin signaling in muscle differentiation26,41–43,
there is a surprising lack of mechanistic insight into how it
fulﬁlls this role. Moreover, recent in vitro and in vivo data
implicating Smad7 in the control of muscle gene
expression is also not understood mechanistically. Inter-
estingly, in one study44 a correlation between TGF-β and
Wnt signaling was investigated where TGF-β1 was
observed to control the differentiation of ﬁbroblasts to
myoﬁbroblasts by upregulating Wnt signaling. Here we
provide evidence of a direct functional interaction
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between Smad7 and β-catenin that serves a fundamental
role in recruiting Mediator components to the well-
characterized ckm gene. Our data indicate that β-catenin
is inefﬁciently recruited to the ckm gene enhancer in
muscle cells when Smad7 is depleted and corresponding
loss of β-catenin recruitment renders this gene incapable
of responding to essential differentiation cues (Fig. 7).
Here we present evidence indicating that a Smad7:
β-catenin complex is a critical part of the transcriptional
machinery at a key muscle promoter proximal element,
being intrinsically necessary as a co-regulator for the
MRFs in the myogenic gene expression program.
Mediator recruitment to ckm by β-catenin/Smad7
The Mediator complex was initially characterized in
budding yeast45 and has since been established as fulﬁlling
an essential function in RNA polymerase II-mediated
gene transcription from ﬂies to mammals46. The multi-
subunit compositional complexity of the Mediator holo-
complex has proved a substantial challenge to deﬁne the
full extent of its properties but what is apparent is that its
fundamental role is to provide a functional bridge
between transcriptional regulatory proteins bound to gene
enhancers and the general transcription machinery
assembled at core promoters47–53. The interaction of
different Mediator subunits with a variety of transcription
factors thus allows a myriad of cellular signaling events
that converge on the transcription factors to be subse-
quently relayed to the transcriptional machinery and
ultimately programs of gene transcription54. Thus, this
essential activity in promoting signal-dependent tran-
scriptional pre-initiation complex (PIC) assembly and
stabilization renders many Mediator subunits essential for
life, since gene targeting in mice has revealed that many
subunits prove embryonic lethal when deleted and in
yeast all Pol II-regulated genes are dependent on Med-
iator52,55–57. The experimental dissection of Mediator has
been aided by the characterization of four relatively stable
sub-complexes that have been designated as the head,
middle, tail, and kinase modules. In our study, we have
documented that the Smad7:β-catenin complex speciﬁ-
cally associates with the MED12 and 13 subunits of the
Mediator kinase module. The kinase domain is speculated
to fulﬁll a transient regulatory function in Mediator by
promoting recruitment of all four Mediator domains to
enhancers which then transitions to a core promoter-
Fig. 4 Smad7 and β-catenin co-operativity on ckm was mediated through MyoD. a C2C12 cells were transfected with small interfering RNAs
targeting β-catenin to deplete the endogenous β-catenin levels. Smad7-myc was transfected along with ckm luciferase reporter gene. b MyoD and
Smad7-myc alone or in combination were transfected along with ckm luciferase promoter activity reporter gene in depleted β-catenin condition.
Empty vector (pcDNA) was used as a control for ectopic expression; Renilla Luciferase was used to normalize for transfection efﬁciency. Lysates were
collected at 48 h after changing to differentiation media (DM) post-transfection. Each condition is compared to the control for the three individually
transfected samples to determine fold change. Each dot represents one biological replicate, which corresponds to the mean of three technical
replicates. N= 3 biological replicates per condition. The error bars represent standard error of the mean (SEM). Dunnett’s multiple comparisons test in
one-way analysis of variance using GraphPad Prism 8.0 was utilized to test for statistical signiﬁcance. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001
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bound Mediator complex in which the kinase module is
absent. We therefore propose that Mediator recruitment
to the ckm enhancer is mediated by the Smad7:β-catenin
complex in muscle cells (Fig. 7).
Implications of β-catenin:Smad7 interaction in
Rhabdomyosarcoma (RMS)
In view of the role played by β-catenin: Smad7, it is
perhaps worth consideration of the implications of this in
the context of the pathology of RMS, a soft tissue pedia-
tric cancer with features of muscle58. Previously, we
reported that constitutive glycogen synthase kinase 3
(GSK3) activity is a feature of the embryonal form of RMS
(there are two general categories: alveolar (ARMS) and
embryonal (ERMS)). The result of this GSK3 activity is
perpetual proteosomal degradation of β-catenin since this
is the primary function of the APC-GSK3 complex in
canonical Wnt signaling59. Upon Wnt signaling stimula-
tion, GSK3 activity is substantially reduced and proteo-
somal degradation of β-catenin ceases, resulting in its
cytoplasmic accumulation and translocation to the
nucleus where it activates transcription in combination
with other transcriptional regulators, such as TCF/LEF.
Based on these previous observations and the current
study, it is worth speculating that the absence of nuclear
β-catenin function due to constitutive GSK3 activity
contributes to the differentiation defect in ERMS. Pro-
moting terminal differentiation of the myo-like cells in
RMS is seen as a potentially effective therapeutic target,
since differentiation, by nature, results in cell cycle with-
drawal and cessation of proliferation which would cause
tumor regression. There are several lines of indirect evi-
dence supporting this idea; we recently reported that
Myogenin is expressed at high levels in RMS but, despite
the role of this MRF as a key terminal effector of the
myogenic differentiation program, it is functionally inac-
tive in these cells. It is therefore possible that the lack of
nuclear β-catenin underlies this functional impairment
due to the failure to recruit Mediator to connect Myo-
genin function to PIC assembly in these ERMS cells. In
support of this possibility, we observed that Smad7:
β-catenin is tethered to muscle promoters by its
Fig. 5 β-Catenin aa575-683 (Smad7- interacting domain (SID)) functions as a dominant-negative inhibitor of endogenous β-catenin
activity. a Smad7-myc and β-catenin-myc alone or in combination were transfected along with increasing amounts of either EYFP-β-catenin SID or
Flag β-catenin SID and ckm luciferase construct. Empty vector (pcDNA) was used as a control. Lysates were collected at 48 h after changing to
differentiation media (DM) post-transfection. Each condition was compared to the control for the three individually transfected samples to determine
fold change. Each dot represents one biological replicate, which corresponds to the mean of three technical replicates. N= 3 biological replicates per
condition. The error bars represent standard error of the mean (SEM). Dunnett’s multiple comparisons test in one-way analysis of variance using
GraphPad Prism 8.0 was utilized to test for statistical signiﬁcance. **p ≤ 0.01, ***p ≤ 0.001. b Total cell lysates of ectopically expressing Flag β-catenin
SID were collected at 48 and 72 h after changing to DM post-transfection. Un-transfected cells served as controls. Cell lysates were analyzed for
endogenous β-catenin, muscle markers (Ckm, Myogenin), and Flag (β-catenin SID) by western blot analysis. An actin blot indicated protein loading of
samples
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Fig. 6 Mediator subunit 13 (MED13) associates with Smad7 in a β-catenin-dependent manner. a C2C12 cells were transiently transfected with
Smad7-ﬂag. Lysates were collected at 24 h after replenishing media post-transfection. Co-immunoprecipitation (Co-IP) assays were performed using
anti-Flag antibody to test an interaction between endogenous MED13 and Smad7. b Co-IP assays were performed using β-catenin antibody to test
for an interaction between endogenous MED12 and β-catenin. IP with IgG served as controls. c Small interfering RNAs (siRNAs) speciﬁc for β-catenin
were used to deplete the endogenous β-catenin levels in C2C12, Scrambled siRNA served as controls. Lysates were collected at 48 h post-transfection
and immunoblotted for β-catenin, anti-Flag (for Smad7-Flag), and Actin (loading control). d Co-IP with anti-Flag was repeated in depleted β-catenin
conditions to assess the interaction between endogenous MED13 and Smad7
Fig. 7 Proposed model of Smad7:β-catenin integration into the transcriptional holocomplex on the ckm proximal promoter region. The
core ckm promoter proximal region contains essential binding sites for MEF2 proteins and MyoD/E protein complexes. β-catenin has also been
previously implicated in binding to MyoD and MEF2 transcription factors. The trithorax group protein Ash2L was previously established as one of the
interacting partners of MEF2D/2A. Based on the published work and the Smad7:β-catenin:MED12/13 contribution identiﬁed herein, an integrated
model of the transcriptional regulation of the ckm gene is proposed
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interaction with MRFs (such as MyoD and Myogenin)
bound to E boxes on muscle promoter/enhancer regions.
Another line of circumstantial evidence supporting this
notion is that pharmacological GSK3 inhibitors have been
reported to force RMS cells into a more differentiated
cellular phenotype, suggesting that re-constitution of
β-catenin function in RMS cells promotes their differ-
entiation and could potentially be antitumorigenic. Fur-
ther clariﬁcation of the role of β-catenin:Smad7 as a
therapeutic target in RMS is therefore warranted.
Further implications of p38 mitogen-activated protein
kinase (MAPK) signaling on ckm regulation
Phospho-dependent protein interactions are a signature
of β-catenin function. There is ample evidence of kinase-
mediated phosphorylation modulating the afﬁnity of PPIs
in the canonical Wnt pathway, resulting in important
outcomes for Wnt-dependent target gene activation33.
Speciﬁcally, we recently reported that a p38 MAPK-
dependent interaction with the MEF2 transcription factor
enhances β-catenin nuclear retention and activity33.
During differentiation, MyoD and MEF2 bind muscle-
speciﬁc promoters and enhancers, leading to the recruit-
ment of co-activators (including p300) and the basal
transcriptional machinery to establish a transcriptionally
poised promoter. The previously implicated mechanism is
that p38 MAPK activates ckm expression by
phosphorylation-dependent recruitment of the histone
methyltransferase Ash2L by MEF2D60. In view of the
current observations, it is also possible that p38 MAPK
may promote β-catenin recruitment to ckm through its
interaction with MEF2.
In summary, we have documented a PPI between Smad7
and β-catenin that may serve a fundamental role in the
control of myogenic gene transcription. These observa-
tions may have implications for our understanding of the
molecular control of myogenic differentiation during
embryonic development and adult muscle regeneration.
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